Evidence mapPaperPMID 36071220Full record

ReviewEuropean journal of nuclear medicine and molecular imaging2023

Paola Gargiulo, Wanda Acampa, Gaetano Asile, Vincenza Abbate, Ermanno Nardi, Federica Marzano, Roberta Assante, Carmela Nappi, Antonio Luca Maria Parlati, Christian Basile and 4 more

Open access · hybridAbstract readReview
In one paragraph

Review in European journal of nuclear medicine and molecular imaging, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Quantitative evaluation ofAnnals of nuclear medicine · 2026
    Article
  3. Article
  4. Establishment of aAnnals of nuclear medicine · 2025
    Article
  5. Review
  6. Novel Strategies in Diagnosing Heart Failure with Preserved Ejection Fraction: A Comprehensive Literature Review.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2024
    Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Paola GargiuloDepartment of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.
Wanda AcampaDepartment of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.
Gaetano AsileDepartment of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.
Vincenza AbbateDepartment of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.
Ermanno NardiDepartment of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.
Federica MarzanoIRCCS Synlab SDN, Naples, Italy.
Roberta AssanteDepartment of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.
Carmela NappiDepartment of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.
Antonio Luca Maria ParlatiDepartment of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.
Christian BasileDepartment of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.
Santo DellegrottaglieDivision of Cardiology, Ospedale Accreditato Villa dei Fiori, Acerra, Naples, Italy.
Stefania PaolilloDepartment of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.
Alberto CuocoloDepartment of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.
Pasquale Perrone-FilardiDepartment of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy. fpperron@unina.it.
University of Naples Federico II · ITClinica Mediterranea · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeHeart failure (HF) is a primary cause of morbidity and mortality worldwide, with significant impact on life quality and extensive healthcare costs. Assessment of myocardial sympathetic innervation function plays a central role in prognosis assessment in HF patients. The aim of this review is to summarize the most recent evidence regarding the clinical applications of iodine-123 metaiodobenzylguanidine (

methodsA comprehensive literature search was conducted on PubMed and Web of Science databases. Articles describing the impact of

resultsWe collected several data reporting that

conclusionComorbidities and chronic conditions lead to more severe impairment of sympathetic nervous system in patients with HF, with a negative impact on disease progression and outcome. Cardiac imaging with

Indexed as

3-IodobenzylguanidineHeart FailureAdrenergic AgentsHeartHumansIodine RadioisotopesRadiopharmaceuticalsSympathetic Nervous System3-IodobenzylguanidineAdrenergic AgentsIodine-123Iodine RadioisotopesRadiopharmaceuticals123I-MIBGDiabetes mellitusHeart failureKidney dysfunctionMyocardial sympathetic innervationObesitySleep-disordered breathing

Identifiers

PMID36071220
PMCPMC9852124
OpenAlexW4294992126

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.